A high-throughput assay to identify small-molecule modulators of alternative pre-mRNA splicing

Journal of Biomolecular Screening

Volumn 18, Issue 2, 2013, Pages 180-190

  Arslan, Ahmet Dirim ^a   He, Xiaolong ^a   Wang, Minxiu ^a   Rumschlag Booms, Emily ^a   Rong, Lijun ^a   Beck, William T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

alternative splicing; cell based HTS; fluorescence methods; ovarian cancer; PTB

Indexed keywords

DIMETHYL SULFOXIDE; ENHANCED GREEN FLUORESCENT PROTEIN; MESSENGER RNA PRECURSOR; POLYPYRIMIDINE TRACT BINDING PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; EXON; FLUORESCENCE; FLUOROMETRY; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; KINETICS; MALIGNANT NEOPLASTIC DISEASE; PERFORMANCE; PRIORITY JOURNAL; REPORTER GENE; UPREGULATION;

ALTERNATIVE SPLICING; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION; GENES, REPORTER; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NERVE TISSUE PROTEINS; POLYPYRIMIDINE TRACT-BINDING PROTEIN; REPRODUCIBILITY OF RESULTS; RNA PRECURSORS; SMALL MOLECULE LIBRARIES;

EID: 84872534036     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057112459901     Document Type: Article

References (33)

1. Wang E. T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., Kingsmore S. F., Schroth G. P., Burge C. B.. Alternative Isoform Regulation in Human Tissue Transcriptomes. Nature. 2008 ; 456: 470-476
2. Pan Q., Shai O., Lee L. J., Frey B. J., Blencowe B. J.. Deep Surveying of Alternative Splicing Complexity in the Human Transcriptome by High-Throughput Sequencing. Nat. Genet. 2008 ; 40: 1413-1415
3. Cooper T. A., Wan L., Dreyfuss G.. RNA and Disease. Cell. 2009 ; 136: 777-793
4. David C. J., Manley J. L.. Alternative Pre-mRNA Splicing Regulation in Cancer: Pathways and Programs Unhinged. Genes Dev. 2010 ; 24: 2343-2364
5. Ghigna C., Valacca C., Biamonti G.. Alternative Splicing and Tumor Progression. Curr. Genomics. 2008 ; 9: 556-570
6. Matlin A. J., Clark F., Smith C. W.. Understanding Alternative Splicing: Towards a Cellular Code. Nat. Rev. Mol. Cell Biol. 2005 ; 6: 386-398
7. Manley J. L., Tacke R.. SR Proteins and Splicing Control. Genes Dev. 1996 ; 10: 1569-1579
8. Zerbe L. K., Pino I., Pio R., Cosper P. F., Dwyer-Nield L. D., Meyer A. M., Port J. D., Montuenga L. M., Malkinson A. M.. Relative Amounts of Antagonistic Splicing Factors, hnRNP A1 and ASF/SF2, Change during Neoplastic Lung Growth: Implications for Pre-mRNA Processing. Mol. Carcinog. 2004 ; 41: 187-196
9. Wagner E. J., Garcia-Blanco M. A.. Polypyrimidine Tract Binding Protein Antagonizes Exon Definition. Mol. Cell. Biol. 2001 ; 21: 3281-3288
10. Tillmar L., Carlsson C., Welsh N.. Control of Insulin mRNA Stability in Rat Pancreatic Islets: Regulatory Role of a 3′-Untranslated Region Pyrimidine-Rich Sequence. J. Biol. Chem. 2002 ; 277: 1099-1106
11. Kafasla P., Morgner N., Robinson C. V., Jackson R. J.. Polypyrimidine Tract-Binding Protein Stimulates the Poliovirus IRES by Modulating eIF4G Binding. EMBO J. 2010 ; 29: 3710-3722
12. Patton J. G., Mayer S. A., Tempst P., Nadal-Ginard B.. Characterization and Molecular Cloning of Polypyrimidine Tract-Binding Protein: A Component of a Complex Necessary for Pre-mRNA Splicing. Genes Dev. 1991 ; 5: 1237-1251
13. He X., Ee P. L., Coon J. S., Beck W. T.. Alternative Splicing of the Multidrug Resistance Protein 1/ATP Binding Cassette Transporter Subfamily Gene in Ovarian Cancer Creates Functional Splice Variants and Is Associated with Increased Expression of the Splicing Factors PTB and SRp20. Clin. Cancer Res. 2004 ; 10: 4652-4660
14. He X., Pool M., Darcy K. M., Lim S. B., Auersperg N., Coon J. S., Beck W. T.. Knockdown of Polypyrimidine Tract-Binding Protein Suppresses Ovarian Tumor Cell Growth and Invasiveness In Vitro. Oncogene. 2007 ; 26: 4961-4968
15. Jin W., McCutcheon I. E., Fuller G. N., Huang E. S., Cote G. J.. Fibroblast Growth Factor Receptor-1 Alpha-Exon Exclusion and Polypyrimidine Tract-Binding Protein in Glioblastoma Multiforme Tumors. Cancer Res. 2000 ; 60: 1221-1224
16. Singh R., Valcarcel J., Green M. R.. Distinct Binding Specificities and Functions of Higher Eukaryotic Polypyrimidine Tract-Binding Proteins. Science. 1995 ; 268: 1173-1176
17. Heider K. H., Kuthan H., Stehle G., Munzert G.. CD44v6: A Target for Antibody-Based Cancer Therapy. Cancer Immunol. Immunother. 2004 ; 53: 567-579
18. Santimaria M., Moscatelli G., Viale G. L., Giovannoni L., Neri G., Viti F., Leprini A., Borsi L., Castellani P., Zardi L., et al. Immunoscintigraphic Detection of the ED-B Domain of Fibronectin, a Marker of Angiogenesis, in Patients with Cancer. Clin. Cancer Res. 2003 ; 9: 571-579
19. Kaida D., Motoyoshi H., Tashiro E., Nojima T., Hagiwara M., Ishigami K., Watanabe H., Kitahara T., Yoshida T., Nakajima H., et al. Spliceostatin A Targets SF3b and Inhibits Both Splicing and Nuclear Retention of Pre-mRNA. Nat. Chem. Biol. 2007 ; 3: 576-583
20. Kotake Y., Sagane K., Owa T., Mimori-Kiyosue Y., Shimizu H., Uesugi M., Ishihama Y., Iwata M., Mizui Y.. Splicing Factor SF3b as a Target of the Antitumor Natural Product Pladienolide. Nat. Chem. Biol. 2007 ; 3: 570-575
21. He X., Arslan A. D., Pool M. D., Ho T. T., Darcy K. M., Coon J. S., Beck W. T.. Knockdown of Splicing Factor SRp20 Causes Apoptosis in Ovarian Cancer Cells and Its Expression Is Associated with Malignancy of Epithelial Ovarian Cancer. Oncogene. 2011 ; 30: 356-365
22. Zhang J. H., Chung T. D., Oldenburg K. R.. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999 ; 4: 67-73
23. Iversen P. W., Eastwood B. J., Sittampalam G. S., Cox K. L.. A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z′ Factor, and Assay Variability Ratio. J. Biomol. Screen. 2006 ; 11: 247-252
24. Spellman R., Llorian M., Smith C. W.. Crossregulation and Functional Redundancy between the Splicing Regulator PTB and Its Paralogs nPTB and ROD1. Mol. Cell. 2007 ; 27: 420-434
25. Barile F. A., Dierickx P. J., Kristen U.. In Vitro Cytotoxicity Testing for Prediction of Acute Human Toxicity. Cell Biol. Toxicol. 1994 ; 10: 155-162
26. Kain S. R.. Green Fluorescent Protein (GFP): Applications in Cell-Based Assays for Drug Discovery. Drug Discov. Today. 1999 ; 4: 304-312
27. Sui Y., Wu Z.. Alternative Statistical Parameter for High-Throughput Screening Assay Quality Assessment. J. Biomol. Screen. 2007 ; 12: 229-234
28. Nasim M. T., Chowdhury H. M., Eperon I. C.. A Double Reporter Assay for Detecting Changes in the Ratio of Spliced and Unspliced mRNA in Mammalian Cells. Nucleic Acids Res. 2002 ; 30: e109
29. Weg-Remers S., Ponta H., Herrlich P., Konig H.. Regulation of Alternative Pre-mRNA Splicing by the ERK MAP-Kinase Pathway. EMBO J. 2001 ; 20: 4194-4203
30. Hodges D., Crooke S. T.. Inhibition of Splicing of Wild-Type and Mutated Luciferase-Adenovirus Pre-mRNAs by Antisense Oligonucleotides. Mol. Pharmacol. 1995 ; 48: 905-918
31. Lagisetti C., Pourpak A., Goronga T., Jiang Q., Cui X., Hyle J., Lahti J. M., Morris S. W., Webb T. R.. Synthetic mRNA Splicing Modulator Compounds with In Vivo Antitumor Activity. J. Med. Chem. 2009 ; 52: 6979-6990
32. Imbert P. E., Unterreiner V., Siebert D., Gubler H., Parker C., Gabriel D.. Recommendations for the Reduction of Compound Artifacts in Time-Resolved Fluorescence Resonance Energy Transfer Assays. Assay Drug Dev. Technol. 2007 ; 5: 363-372
33. David C. J., Chen M., Assanah M., Canoll P., Manley J. L.. HnRNP Proteins Controlled by c-Myc Deregulate Pyruvate Kinase mRNA Splicing in Cancer. Nature. 2010 ; 463: 364-368